title: Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis.
authors.forename: Peter D
authors.initials: PD
authors.lastname: Kent
authors.forename: John M
authors.initials: JM
authors.lastname: Davis
authors.forename: Mark D P
authors.initials: MD
authors.lastname: Davis
authors.forename: Eric L
authors.initials: EL
authors.lastname: Matteson
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D011241:Prednisone